LivaNova PLC
Electromedical & Electrotherapeutic Apparatus
Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
What LivaNova PLC reports
Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.
Where the employee count comes from
Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.
Insiders at LivaNova PLC
Shares is what each person last reported holding here.
Everyone below has filed at least one insider report against this company.
Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.
Rows are grouped by the role each person reports.
The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.
| Insider | Reported role | Shares | Value | Last action |
|---|---|---|---|---|
| Officers 3 | ||||
Alex Shvartsburg
|
CFO | 26,680 | $2.19M | F Shares withheld for taxes Mar 30, 2026 position reported |
| Trui Hebbelinck | Other Executive | 13,779 | $1.13M | M Option exercise or conversion Mar 30, 2024 position reported |
Stephanie Bolton
|
President | 12,751 | $1.04M | F Shares withheld for taxes Mar 30, 2026 position reported |
| Directors 5 | ||||
William A. Kozy
|
Board Member | 32,567 | $2.67M | F Shares withheld for taxes Jun 15, 2026 position reported |
| Daniel Jeffrey Moore | Board Member | 27,534 | $2.26M | S Open-market sale Jun 3, 2024 position reported |
Todd C. Schermerhorn
|
Board Member | 9,063 | $742.4K | F Shares withheld for taxes Jun 15, 2026 position reported |
| Peter M. Wilver | Board Member | 6,738 | $552.0K | F Shares withheld for taxes Jun 15, 2026 position reported |
Susan M. Podlogar
|
Board Member | 2,086 | $170.9K | F Shares withheld for taxes Jun 15, 2026 position reported |
Recent insider transactions
Of the 45 rows we hold, 0 are open-market purchases and 2 open-market sales (S) — the only codes we count as buying or selling.
The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.
A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Peter M. Wilver | F Shares withheld for taxes | 486 | $79.70 | $38.7K | SEC filing ↗ |
| Jun 15, 2026 | Peter M. Wilver | M Option exercise or conversion | 4,042 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2026 | Todd C. Schermerhorn | F Shares withheld for taxes | 486 | $79.70 | $38.7K | SEC filing ↗ |
| Jun 15, 2026 | Todd C. Schermerhorn | M Option exercise or conversion | 4,042 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2026 | Susan M. Podlogar | F Shares withheld for taxes | 486 | $79.70 | $38.7K | SEC filing ↗ |
| Jun 15, 2026 | Susan M. Podlogar | M Option exercise or conversion | 4,042 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2026 | William A. Kozy | F Shares withheld for taxes | 682 | $79.70 | $54.4K | SEC filing ↗ |
| Jun 15, 2026 | William A. Kozy | M Option exercise or conversion | 5,681 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2026 | Donald Zurbay | F Shares withheld for taxes | 308 | $79.70 | $24.5K | SEC filing ↗ |
| Jun 15, 2026 | Donald Zurbay | M Option exercise or conversion | 2,560 | $0.00 | $0 | SEC filing ↗ |
| Mar 30, 2026 | Alex Shvartsburg | F Shares withheld for taxes | 12,868 | $61.27 | $788.4K | SEC filing ↗ |
| Mar 30, 2026 | Alex Shvartsburg | M Option exercise or conversion | 30,835 | $0.00 | $0 | SEC filing ↗ |
| Mar 30, 2026 | Stephanie Bolton | F Shares withheld for taxes | 8,377 | $61.27 | $513.3K | SEC filing ↗ |
| Mar 30, 2026 | Stephanie Bolton | M Option exercise or conversion | 17,815 | $0.00 | $0 | SEC filing ↗ |
| Dec 15, 2025 | Susan M. Podlogar | F Shares withheld for taxes | 269 | $63.06 | $17.0K | SEC filing ↗ |
| Dec 15, 2025 | Susan M. Podlogar | M Option exercise or conversion | 2,355 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2025 | Peter M. Wilver | F Shares withheld for taxes | 410 | $45.76 | $18.8K | SEC filing ↗ |
| Jun 15, 2025 | Peter M. Wilver | M Option exercise or conversion | 3,416 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2025 | William A. Kozy | F Shares withheld for taxes | 581 | $45.76 | $26.6K | SEC filing ↗ |
| Jun 15, 2025 | William A. Kozy | M Option exercise or conversion | 4,840 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2025 | Todd C. Schermerhorn | M Option exercise or conversion | 3,416 | $0.00 | $0 | SEC filing ↗ |
| Jun 15, 2025 | Todd C. Schermerhorn | F Shares withheld for taxes | 410 | $45.76 | $18.8K | SEC filing ↗ |
| Mar 30, 2025 | Stephanie Bolton | M Option exercise or conversion | 6,024 | $0.00 | $0 | SEC filing ↗ |
| Mar 30, 2025 | Stephanie Bolton | F Shares withheld for taxes | 2,835 | $39.13 | $110.9K | SEC filing ↗ |
| Mar 30, 2025 | Alex Shvartsburg | F Shares withheld for taxes | 3,516 | $39.13 | $137.6K | SEC filing ↗ |
From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.
What a Form 4 is
The report an officer, director or large shareholder must file after trading their own company’s stock.
Subsidiaries — 43 legal entities
Subsidiaries of LivaNova PLC
43 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.
This is not the full list. SEC rules only require a company to name its significant subsidiaries.
What that leaves out
Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.
| Subsidiary | Organised in |
|---|---|
| ALung Technologies, LLC | USA |
| Caisson Interventional, LLC | USA |
| CardiacAssist, LLC Dba TandemLife | USA |
| Cyberonics Holdings, LLC | USA |
| Cyberonics Netherlands CV | Netherlands |
| ImThera Medical, Inc. | USA |
| LivaNova (China) Medical Technology Co. Ltd | China |
| LivaNova (Thailand) Ltd | Thailand |
| LivaNova Australia PTY Limited | Australia |
| LivaNova Austria GmbH | Austria |
| LivaNova Belgium N.V. | Belgium |
| LivaNova Brasil Comércio e Distribuição de Equipamentos Médico-hospitalares Ltda | Brazil |
| LivaNova Canada, Inc. | Canada |
| LivaNova Chile SpA | Chile |
| LivaNova Colombia Sas | Colombia |
| LivaNova Deutschland GmbH | Germany |
| LivaNova Espana, S.L. | Spain |
| LivaNova Finland Oy | Finland |
| LivaNova Holding S.r.l. | Italy |
| LivaNova Hong Kong Limited | Hong Kong |
| LivaNova India Private Limited | India |
| LivaNova IP Limited | United Kingdom |
| LivaNova Japan K.K. | Japan |
| LivaNova Korea Limited | Korea |
| LivaNova Malaysia Sdn. Bhd. | Malaysia |
| LivaNova Nederland N.V. | Netherlands |
| LivaNova Norway AS | Norway |
| LivaNova Poland Sp. Z o.o. | Poland |
| LivaNova Regional Headquarter Company | Saudi Arabia |
| LivaNova SAS | France |
| LivaNova Scandinavia AB | Sweeden |
| LivaNova Singapore Pte Ltd | Singapore |
| LivaNova Site Management S.r.l. | Italy |
| LivaNova Switzerland SA | Switzerland |
| LivaNova Taiwan Co. Ltd | Taiwan |
| LivaNova Turkey Medikal Limited Sirketi | Turkey |
| LivaNova UK Limited | United Kingdom |
| LivaNova USA, Inc. | USA |
| LivaNova, Inc. | USA |
| LIVN Irishco 2 UC | Ireland |
| LIVN US 3, LLC | USA |
| Sorin Group Italia S.r.l. | Italy |
| Sorin Group Rus LLC | Russia |
What counts as a subsidiary
A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.
Think a number here is wrong? Open the linked filing and compare — how to report it.
Sources and technical notes
Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.
Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from
LivaNova PLC’s own filings and multiplied by our closing price.
Full method.
What that share count means
the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.
We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from LivaNova PLC’s own SEC filings multiplied by the closing price we hold for the same stock.